Y chromosome instability in testicular cancer

Mutation Research - Reviews in Mutation Research

Volumn 612, Issue 3, 2006, Pages 172-188

  Bianchi, Néstor O ^a   Richard, Silvina M ^a   Pavicic, Walter ^a  

^a Instituto Multidisciplinario de Biologia Celular   (Argentina)

Author keywords

AZF deletions; Testicular cancer; Y chromosome instability

Indexed keywords

ACYLTRANSFERASE; CYTOCHROME P450 1A2;

AZF GENE; CARCINOMA IN SITU; CHROMOSOMAL INSTABILITY; CHROMOSOME DELETION; CHROMOSOME MARKER; CHROMOSOME STRUCTURE; FERTILIZATION; GENE; GENE DELETION; GENETIC ASSOCIATION; GENOMIC INSTABILITY; GEOGRAPHIC DISTRIBUTION; GERM CELL TUMOR; HUMAN; OOCYTE; PRIORITY JOURNAL; REVIEW; SEMINOMA; SEX CHROMOSOME MOSAICISM; SPERM; TESTIS CANCER; TOTIPOTENT STEM CELL; Y CHROMOSOME;

CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, Y; FINLAND; GENE DELETION; HUMANS; INFERTILITY, MALE; MALE; SEMINAL PLASMA PROTEINS; TESTICULAR NEOPLASMS;

EID: 33646811153     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2005.12.001     Document Type: Review

References (87)

1. Bianchi N.O., Richard S.M., Peltomäki P., and Bianchi M.S. Mosaic AZF deletions and susceptibility to testicular tumors. Mutat. Res. 503 (2002) 51-62
2. Lahn B.T., and Page D.C. Functional coherence of the human Y chromosome. Science 278 (1997) 675-680
3. Skaletsky H., Kuroda-Kawaguchi T., Minx P.J., Cordum H.S., Hiller L.D., Brown L.G., et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423 (2003) 825-837
4. Kuroda-Kawaguchi T., Skaletsky H., Brown L.G., Minx P.J., Cordum H.S., Waterston R.H., Wilson R.K., Silber S., Oates R., Rozen S., and Page D.C. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat. Genet. 29 (2001) 279-286
5. Rozen S., Skaletsky H., Marszalek J.D., Minx P.J., Cordum H.S., Waterston R.H., Wilson R.K., and Page D.C. Abundant gene conversion between arms of palindromes in human and ape Y chromosomes. Nature 423 (2003) 873-876
6. Padhukasahasram B., Marjoram P., and Nordborg M. Estimating the rate of gene conversion on human chromosome 21. Am. J. Hum. Genet. 75 (2004) 386-397
7. Jeffreys A.J., and May C.A. Intense and highly localized gene conversion activity in human meiotic crossover hot spots. Nat. Genet. 36 (2004) 114-115
8. Santos F.R., Hutz M., Coimbra C.E.A., Santos R.V., Salzano F.M., and Pena S.D.J. Further evidence for the existence of a major founder Y chromosome haplotype in Amerindians. Braz. J. Genet. 18 (1995) 669-672
9. Santos F.R., Rodríguez-Delfin L., Pena S.D.J., Moore J., and Weiss K.M. North and South Amerindians may have the same major founder Y chromosome. Am. J. Hum. Genet. 58 (1996) 1369-1370
10. Callinan P.A., Hedges D.J., Salem A.H., Xing J., Walker J.A., Garber R.K., Scott Watkins W., Bamshad M.J., Jorde L.B., and Batzer M.A. Comprehensive analysis of Alu-associated diversity on the human sex chromosomes. Gene 37 (2003) 103-110
11. Sun C., Skaletsky H., Rozen S., Gromoll J., Nieschlag E., Oates R., and Page D.C. Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses. Hum. Mol. Genet. 9 (2000) 2291-2296
12. Reijo R., Lee T.Y., Salo P., Alagappan R., Brown L.G., Rosenberg M., Rozen S., Jaffe T., Straus D., and Hovatta O. Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat. Genet. 10 (1995) 383-393
13. Vogt P.H., Edelmann A., Kirsch S., Henegariu O., Hirschmann P., Kiesewetter F., et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum. Mol. Genet. 5 (1996) 933-943
14. Stuppia L., Calabrese G., Franchi P., et al. Widening of a Y chromosome interval-6 deletion transmitted from a father to his infertile son accounts for an oligozoospermia critical region distal to the RBM1 and DAZ genes. Am. J. Hum. Genet. 59 (1996) 1393-1395
15. Stuppia L., Gatta V., Mastroprimiano G., Pompetti F., Calabrese G., Guanciali Franchi P., Morizio E., Mingarelli R., Nicolai M., Tenaglia R., Sforza V., Bisceglia S., and Palka G. Clustering of Y chromosome deletions in subinterval E of interval 6 supports the existence of an oligozoospermia critical region outside the DAZ gene. J. Med. Genet. 34 (1997) 881-883
16. Stuppia L., Gatta V., Calabrese G., Guanciali Franchi P., Morizio E., Bombieri C., Mingarelli R., Sforza V., Frajese G., Tenaglia R., and Palka G. A quarter of men with idiopathic oligozoospermia display chromosomal abnormalities and microdeletions of different types in interval 6 of Yq11. Hum. Genet. 102 (1998) 566-570
17. Pryor J.L., Kent-First M., Muallem A., Van Bergen A.H., Nolten W.E., Meisner L., and Roberts K.P. Microdeletions of the Y chromosome of infertile men. N. Engl. J. Med. 336 (1997) 534-539
18. Foresta C., Ferlin A., Garolla A., Moro E., Pistorello M., Barbauz S., et al. High frequency of well-defined Y-chromosome deletions in idiopathic Sertoli cell-only syndrome. Hum. Reprod. 13 (1998) 302-307
19. Kent-First M., Muallem A., Shultz J., Pryor J., Roberts K., Nolten W., Meisner L., Chandley A., Gouchy G., Jorgensen L., Havighurst T., and Grosch J. Defining regions of the Y-chromosome responsible for male infertility and identification of a fourth AZF region (AZFd) by Y-chromosome microdeletion detection. Mol. Reprod. Dev. 53 (1999) 27-41
20. Seifer I., Amat S., Delgado-Viscogliosi P., Boucher D., and Bignon Y.J. Screening for microdeletions on the long arm of chromosome Y in 53 infertile men. Int. J. Androl. 22 (1999) 148-154
21. McElreavey K., and Krausz C. Sex chromosome genetics 99: male infertility and the Y chromosome. Am. J. Hum. Genet. 64 (1999) 928-933
22. Tiepolo L., and Zuffardi O. Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum. Genet. 34 (1976) 119-124
23. Kamp C., Hirschmann P., Voss H., Huellen K., and Vogt P.H. Two long homologous retroviral sequence blocks in proximal Yq11 cause AZFa microdeletions as a result of intrachromosomal recombination events. Hum. Mol. Genet. 9 (2000) 2563-2572
24. Sargent C.A., Boucher C.A., Kirsch S., Brown G., Weiss B., Trundley A., Burgoyne P., Saut N., Durand C., Levy N., Terriou P., Hargreave T., Cooke H., Mitchell M., Rappold G.A., and Affara N.A. The critical region of overlap defining the AZFa male infertility interval of proximal Yq contains three transcribed sequences. J. Med. Genet. 36 (1999) 670-677
25. Repping S., Skaletsky H., Lange J., Silber S., van der Veen F., Oates R.D., Page D.C., and Rozen S. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am. J. Hum. Genet. 71 (2002) 906-922
26. Ferlin A., Moro E., Rossi A., Dallapiccola B., and Foresta C. The human Y chromosome's azoospermia factor b (AZFb) region: sequence, structure, and deletion analysis in infertile men. J. Med. Genet. 40 (2003) 18-24
27. Aho M., Harkönen K., Suikkari A.M., Juvonen V., Anttila L., and Lähdetie J. Y-chromosomal microdeletions among infertile Finnish men. Acta Obstet. Gynecol. Scand. 80 (2001) 652-656
28. Krausz C., Rajpert-De Meyts E., Frydelund-Larsen L., Quintana-Murci L., McElreavy K., and Skakkebaek N.E. Double-blind Y chromosome microdeletion analysis in men with known sperm parameters and reproductive hormone profiles: microdeletions are specific for spermatogenic failure. J. Clin. Endocrinol. Metab. 86 (2001) 2638-2642
29. Repping S., Skaletsky H., Brown L., van Daalen S.K.M., Korver C.M., Pyntikova T., Kuroda-Kawaguchi T., de Vries J.W.A., Oates R.D., Silber S., van der Veen F., Page D.C., and Rozen S. Polymorphism for a 1.6-Mb deletion of the Y chromosome persists through balance between recurrent mutation and haploid selection. Nat. Genet. 35 (2003) 247-251
30. Repping S., van Daalen S.K.M., Korver C.M., Brown L.G., Marszalek J.D., Gianotten J., Oates R.D., Silber S., van der Veen F., Page D.C., and Rozen S. A family of human Y chromosomes has dispersed throughout northern Eurasia despite a 1.8-Mb deletion in the azoospermia factor c region. Genomics 83 (2004) 1046-1052
31. K.L. Nathanson, P.A. Kanetsky, R. Hawes, R. Letrero, D. Dudakia, K. Robertson, L. Johnson, D. Vaughn, M.R. Stratton, E.A. Rapley, International Testicular Cancer Linkage Consortium, The Y deletion gr/gr confers susceptibility to testicular germ cell cancer, Congress of The American Society of Human Genetics (2004)..
32. Jacobsen R., Bostofte E., Engholm G., Hansen J., Skakkebaek N.E., and Moller H. Fertility and offspring sex ratio of men who develop testicular cancer: a record linkage study. Hum. Reprod. 15 (2000) 1958-1961
33. Moller H., and Skakkebaek N.E. Risk of testicular cancer in subfertile men: case-control study. Br. Med. J. 318 (1999) 559-562
34. de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J. Med. Genet. 30 (1993) 857-865
35. Norio R. The Finnish Disease Heritage I: characteristics, causes, background. Hum. Genet. 112 (2003) 441-456
36. Norio R. The Finnish Disease Heritage II: population prehistory and genetic roots of Finns. Hum. Genet. 112 (2003) 457-469
37. Norio R. The Finnish Disease Heritage III: the individual diseases. Hum. Genet. 12 (2003) 470-526
38. Podar T., Solntsev A., Karvonen M., Padaiga Z., Brigis G., Urbonaite B., Viik- Kajander M., Reunanen A., and Tuomilehto J. Increasing incidence of childhood-onset type I diabetes in 3 Baltic countries and Finland 1983-1998. Diabetologia 44 Suppl. 3 (2001) B17-B20
39. Vuorio A.F., Aalto-Setälä K., Koivisto U.M., Turtola H., Nissen H., Kovanen P.T., Miettinen T.A., Gylling H., Oksanen H., and Kontula K. Finnish F-H group. Ann. Med. 33 (2001) 410-421
40. Kittles R.A., Perola M., Peltonen L., Bergen A.W., Aragon R.A., Virkkunen M., Linnoila M., Goldman D., and Long J.C. Dual origins of Finns revealed by Y chromosome haplotype variation. Am. J. Hum. Genet. 62 (1998) 1171-1179
41. Lahermo P., Savontaus M.L., Sistonen P., Beres J., de Kniff P., Aula P., and Sajantila A. Y chromosomal polymorphisms reveal founding lineages in the Finns and the Saami. Eur. J. Hum. Genet. 7 (1999) 447-458
42. Raitio M., Lindroos K., Laukkanen M., Pastinen T., Sistonen P., Sajantila A., and Syvänen A.C. Y chromosomal SNPs in Finno-Ugric-speaking populations analyzed by minisequencing on microarrays. Genome Res. 11 (2001) 471-482
43. Chromosome Consortium. A nomenclature system for the tree of human Y-chromosomal binary haplogroups. Genome Res. 12 (2002) 339-348
44. Jobling M.A., Samara V., Pandya A., Fretwell N., Bernasconi B., Mitchell R.J., et al. Recurrent duplication and deletion polymorphisms on the long arm of the Y chromosome in normal males. Hum. Mol. Genet. 5 (1996) 1767-1775
45. Richard S.M., Bianchi N.O., Bianchi M.S., Peltomäki P., Lothe R.A., and Pavicic W. Ethnic variation in the prevalence of AZF deletions in testicular cancer. Mutat. Res. 554 (2004) 45-51
46. Freydelun-Larsen L., Vogt P.H., Leffers H., Schadwinkel A., Daugaard G., Skakkebaek N.E., and Rajpert-De Meyts E. No AZF deletion in 160 patients with testicular germ cell neoplasia. Mol. Hum. Reprod. 9 (2003) 517-521
47. Lutke-Holzik M.F., Storm K., Sijmons R.H., D'Hollander M., Arts E.G.J.M., Verstraaten M.L., Sleijfer D.T., and Hoekstra H.J. Absence of constitutional Y chromosome AZF deletions in patients with testicular germ cell tumors. Urology 65 (2005) 196-201
48. Adami H.O., Bergstrom R., Mohner M., Zatonski W., Storm H., Ekbom A., et al. Testicular cancer in nine northern European countries. Int. J. Cancer 59 (1994) 33-38
49. Richiardi L., Bellocco R., Adami H.O., Torrang A., Barlow L., Hakulinen T., Rahu M., Stengrevics A., Storm H., Tretli S., Kurtinaitis J., Tyczynski J.E., and Akre O. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 2157-2166
50. McLaren A. Germ and somatic cell lineages in the developing gonad. Mol. Cell. Endocrinol. 163 (2000) 3-9
51. Jorgensen N., Rajpert-De Meyts E., Graem N., Muller J., Giwercman A., and Skakkebaek N.E. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab. Invest. 72 (1995) 223-231
52. Skotheim R.I., and Lothe R.A. The testicular germ cell tumour genome. APMIS III (2003) 136-151
53. Hull M.G., Glazener C.M., Kelly N.J., Conway D.I., Foster P.A., Hinton R.A., Coulson C., Lambert P.A., Watt E.M., and Desai K.M. Population study of causes, treatment, and outcome of infertility. Br. Med. J. 291 (1985) 1693-1697
54. Collick A., Drew J., Penberth J., Bois P., Luckett J., Scaerou F., Jeffreys A., and Reik W. Instability of long inverted repeats within mouse transgenes. EMBO J. 15 (1996) 1163-1171
55. Gordenin D.A., and Resnick M.A. Yeast ARMs (DNA at-risk motifs) can reveal sources of genome instability. Mutat. Res. 400 (1998) 45-58
56. Akgün E., Zahn J., Baumes S., Brown G., Liang F., Romanienko P.J., Lewis S., and Jsin M. Palindrome resolution and recombination in the mammalian germ line. Mol. Cell. Biol. 17 (1997) 5559-5570
57. Lewis S., Akgün E., Jasin M., and Palindromic. DNA and genome stability. Further studies. Ann. N.Y. Acad. Sci. 870 (1999) 45-57
58. Colls B.M., Harvey V.J., Shalton L., Thompson P.I., and Frampton C.M. Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch. J. Clin. Oncol. 7 (1996) 2061-2065
59. Sonneveld D.J.A., Schraffordt Koops H., Sleijfer D.T., and Hoekstra H.J. Bilateral testicular tumors in patients with initial stage I disease: prevalence and prognosis: a single centre 30 years' experience. Eur. J. Cancer 34 (1998) 1363-1367
60. Sonneveld D.J., Sleijfer D.T., Schrafford Koops H., Sijmons R.H., van der Graaf W.T., Sluiter W.J., and Hoekstra H.J. Familial testicular cancer in a single-centre population. Eur. J. Cancer 35 (1999) 1368-1373
61. Oliver R.T.D. Current opinion in cancer 2000. Curr. Opin. Oncol. 12 (2000) 249-254
62. Kuroki Y., Iwamoto T., Lee J., Yoshike M., Nozawa S., Nishida T., et al. Spermatogenic ability is different among males in different Y chromosome lineages. J. Hum. Genet. 44 (1999) 289-292
63. Rapley E.A., Crockford G.P., Hamoudi D., Heimdal K., Fossa S.D., Tucker K., et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumors. Nat. Genet. 24 (2000) 197-200
64. Bergström R., Adami H.O., Mohner M., Zatonski W., Storm H., Ekbom A., et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. H. Natl. Cancer Inst. 88 (1996) 727-733
65. Devesa S.S., Blot W.J., Stone B.J., Miller B.A., Tarone R.E., and Fraumeni J.F.J. Recent cancer trends in the United States. J. Natl. Cancer Inst. 87 (1995) 175-182
66. Ekbom A., and Akre O. Increasing incidence of testicular cancer-birth cohort effects. APMIS 106 (1998) 225-229
67. Czene K., Lichtenstein P., and Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer 99 (2002) 260-266
68. Nebert D.W., McKinnon R.A., and Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol. 15 (1996) 273-280
69. Vistisen K., Loft S., Olsen J.H., Vallentin S., Ottesen S., Hirsch F.R., and Poulsen H.E. Low CYP1A2 activity associated with testicular cancer. Carcinogenesis 25 (2004) 923-929
70. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1239-1248
71. Vistisen K., Prieme H., Okkels H., Vallentin S., Loft S., Olsen J.H., and Poulsen H.E. Genotype and phenotype of glutathione S-transferase mu in testicular cancer patients. Pharmacogenetics 7 (1997) 21-25
72. Peltomäki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 21 (2003) 1174-1179
73. Lothe R.A., Peltomäki P., Tommerup N., Fossä S.D., Stenwig A.E., Borresen A.L., and Nesland J.M. Molecular genetic changes in human male germ cell tumors. Lab. Invest. 73 (1995) 606-614
74. Huddart R.A., Wooster R., Horwich A., and Cooper C.S. Microsatellite instability in human testicular germ-cell tumours. Br. J. Cancer 72 (1995) 642-645
75. Velasco A., Riquelme E., Schultz M., Wistuba II, Villarroel L., Pizarro J., Berlin A., Ittmann M., Koh M.S., and Leach F.S. Mismatch repair gene expression and genetic instability in testicular germ cell tumor. Cancer Biol. Ther. 3 (2004) 977-982
76. Boland R.C., Thibodeau S.N., Hamilton S.R., Sidransky D., Eskleman J.R., Burt R.W., Meltzer S.J., Rodríguez-Vigas M.A., Fodde R., Ranzani N., and Srivastava S. Proceedings of the National Cancer Institute Workshop on the Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer. Cancer Res. 58 (1998) 5248-5257
77. S.M. Richard, Análisis de inestabilidad genómica en tumores de testículo humano, Doctoral Thesis, 2004, pp. 1-94.
78. Fossä S.D., Nesland J.M., Petwersen E.O., Amellem O., Waehre H., and Heimdal K. DNA ploidy in primary testicular cancer. Br. J. Cancer 64 (1991) 948-952
79. de Graaff W.E., Oosterhuis J.W., de Jong B., Dam A., van Putten W.L., Castedo S.M., Sleijfer D.T., and Schraffordt Koops H. Ploidy of testicular carcinoma in situ. Lab. Invest. 66 (1992) 166-168
80. Peltomäki P., Lothe R.A., Borresen A.L., Fossa S.D., Brogger A., and de la Chapelle A. Chromosome 12 in human testicular cancer: dosage changes and their parental origin. Cancer Genet. Cytogenet. 64 (1992) 21-26
81. Rodríguez E., Mathew S., Reuter V., Ilson D.H., Bosl G.J., and Chaganti R.S.K. Cytogenetic analysis of 124 prospectively ascertained male germ-cell tumors. Cancer Res. 52 (1992) 2285-2291
82. Rosenberg C., Van Gurp R.J., Geelen E., Oosterhuis J.W., and Looijenga L.H. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene 19 (2000) 5858-5862
83. Travis L.B., Curtis R.E., Storm H., Hall P., Holowaty E., Van Leeuwen F.E., Kohler B.A., Pukkala E., Lynch C.F., Andersson M., Bergfeldt K., Clarke E.A., Wiklund T., Stoter G., Gospodarowicz M., Sturgeon J., Fraumeni Jr. J.F., and Boice Jr. J.D. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J. Natl. Cancer Inst. 89 (1997) 1429-1439
84. Richard S.M., Knuutila S., Peltomäki P., Bianchi M.S., and Bianchi N.O. Y chromosome instability in lymphoproliferative disorders. Mutat. Res. 525 (2003) 103-107
85. Linke J., Loy V., and Dieckmann K.P. Prevalence of testicular intraepithelial neoplasia in healthy males. J. Urol. 173 (2005) 1577-1579
86. Skotheim R.I., Abeler V.M., Nesland J.M., Fossä S.D., Holm R., Wagner I., Florenes V.A., Aass N., Kallioniemi O.P., and Lothe R.A. Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays. Neoplasia 5 (2003) 397-404
87. Skotheim R.I., Lind G.E., Monni O., Nesland J.M., Abeler V.M., Fossä S.D., Duale N., Brunborg G., Kallioniemi O., Andrews P.W., and Lothe R.A. Differentiation of human embryonal carcinoma, in vitro and in vivo, reveals expression profiles relevant to normal development. Cancer Res. 65 (2005) 5588-5598